Rifampin in CYP24A1-related Hypercalcemia and Hypercalciuria | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Rifampin in CYP24A1-related Hypercalcemia and Hypercalciuria	Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hypercalciuria, Hypercalciuric Hypercalcemia, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urogenital Diseases, Urological Manifestations, Water-Electrolyte Imbalance, calcinosis, calcium metabolic disease, hereditary disease, hypercalcemia disease, hypercalcemia, infantile, kidney disorder, metabolic disease, nephrocalcinosis, urinary system disorder	Recruiting	Phase 2	2026-06-22		NCT03301038

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Children's Hospital of Philadelphia	215
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	617

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Children's Hospital of Philadelphia	Philadelphia	United States	434